Associations - FGFR mutation

BIOMARKER:

FGFR mutation

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

FGFR mutation FGFR mutation	Urothelial Cancer Urothelial Cancer	erdafitinib Sensitive: C2 – Inclusion Criteria erdafitinib Sensitive : C2
FGFR mutation FGFR mutation	Urothelial Cancer Urothelial Cancer	erdafitinib + JNJ-63723283 Sensitive: C3 – Early Trials erdafitinib + JNJ-63723283 Sensitive : C3
FGFR mutation FGFR mutation	Urothelial Cancer Urothelial Cancer	FGFR inhibitor Sensitive: C3 – Early Trials FGFR inhibitor Sensitive : C3
FGFR mutation FGFR mutation	Breast Cancer Breast Cancer	E7090 Sensitive: D – Preclinical E7090 Sensitive : D